Just spent some time digging into healthcare ETFs and honestly, there's way more variety than I expected. If you're thinking about getting exposure to pharma without picking individual stocks, these funds are pretty solid—lower volatility than holding single companies, plus you get that diversification thing working for you. I found that the bigger healthcare ETF plays have AUM ranging from like 86 million to 1.2 billion, so plenty of options depending on your portfolio size. Expense ratios are mostly under 0.65 percent, which is reasonable. The VanEck Pharma ETF (PPH) seems to be the heavyweight with 1.2 billion in assets and a 0.36 percent fee. Top holdings across most of these are the usual suspects—Eli Lilly, Merck, Johnson & Johnson—so you're basically getting a basket of blue-chip pharma plays. There's also the China-focused healthcare ETF if you want international exposure, though it's smaller. Noticed that a lot of these healthcare ETF options started hitting the market back in 2005-2006, so they've been around long enough to have solid track records. The holdings vary though—some lean heavy on oncology and biotech, others are more diversified across pain management and vaccines. Worth looking at if you want sector exposure without the stock-picking headache.